These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38945328)

  • 1. Split intein-mediated backbone cyclization enhances the stability and activity of staphylokinase, a potent fibrin-selective plasminogen activator.
    Baharian A; Ishida H; Sillner C; Vogel HJ
    Int J Biol Macromol; 2024 Aug; 275(Pt 1):133448. PubMed ID: 38945328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the N-terminal region of staphylokinase (SAK): evidence for the participation of the N-terminal region of SAK in the enzyme-substrate complex formation.
    Rajamohan G; Dikshit KL
    FEBS Lett; 2000 Jun; 474(2-3):151-8. PubMed ID: 10838076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylokinase as a plasminogen activator component in recombinant fusion proteins.
    Szarka SJ; Sihota EG; Habibi HR; Wong S
    Appl Environ Microbiol; 1999 Feb; 65(2):506-13. PubMed ID: 9925575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel recombinant thrombolytic and antithrombotic staphylokinase variants with an RGD motif at their N-termini.
    He J; Di J; Xu R; Zhao B
    Biotechnol Appl Biochem; 2008 May; 50(Pt 1):17-23. PubMed ID: 18039183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity--a staphylokinase variant. I. In vitro study.
    Szemraj J; Walkowiak B; Kawecka I; Janiszewska G; Buczko W; Bartkowiak J; Chabielska E
    J Thromb Haemost; 2005 Oct; 3(10):2156-65. PubMed ID: 16150047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylokinase Control of Staphylococcus aureus Biofilm Formation and Detachment Through Host Plasminogen Activation.
    Kwiecinski J; Peetermans M; Liesenborghs L; Na M; Björnsdottir H; Zhu X; Jacobsson G; Johansson BR; Geoghegan JA; Foster TJ; Josefsson E; Bylund J; Verhamme P; Jin T
    J Infect Dis; 2016 Jan; 213(1):139-48. PubMed ID: 26136471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
    Sakai M; Watanuki M; Matsuo O
    Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity - a staphylokinase variant. An in-vivo study.
    Szemraj J; Stankiewicz A; Rozmyslowicz-Szermińska W; Mogielnicki A; Gromotowicz A; Buczko W; Oszajca K; Bartkowiak J; Chabielska E
    Thromb Haemost; 2007 Jun; 97(6):1037-45. PubMed ID: 17549308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylokinase requires NH2-terminal proteolysis for plasminogen activation.
    Schlott B; Gührs KH; Hartmann M; Röcker A; Collen D
    J Biol Chem; 1997 Feb; 272(9):6067-72. PubMed ID: 9038231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
    Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
    Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning & expression of SAK enzyme from
    Muttar A; Numan IT
    J Med Life; 2022 Jun; 15(6):768-771. PubMed ID: 35928367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid modification of staphylokinase and its implications on stability and activity.
    Mannully ST; Shanthi C; Pulicherla KK
    Int J Biol Macromol; 2019 Jan; 121():1037-1045. PubMed ID: 30342946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex.
    Shibata H; Nagaoka M; Sakai M; Sawada H; Watanabe T; Yokokura T
    J Biochem; 1994 Apr; 115(4):738-42. PubMed ID: 8089091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refolding of a staphylokinase variant y1-Sak by reverse dilution.
    He J; Wang G; Xu R; Feng J; Wang J; Su H; Song H
    Appl Biochem Biotechnol; 2008 Oct; 151(1):29-41. PubMed ID: 18785020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and intein-mediated purification of novel staphylokinase SakSTAR with reduced immunogenicity and antiplatelet and antithrombin activation.
    Kochanowski R; Kotlowski R; Szweda P
    Appl Biochem Biotechnol; 2007; 141(2-3):321-33. PubMed ID: 18025559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections.
    Peetermans M; Vanassche T; Liesenborghs L; Claes J; Vande Velde G; Kwiecinksi J; Jin T; De Geest B; Hoylaerts MF; Lijnen RH; Verhamme P
    BMC Microbiol; 2014 Dec; 14():310. PubMed ID: 25515118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin.
    Okada K; Yuasa H; Hagiya Y; Fukao H; Ueshima S; Matsuo O
    Thromb Res; 1994 Oct; 76(2):181-91. PubMed ID: 7863467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional basis of plasminogen activation by staphylokinase.
    Jespers L; Vanwetswinkel S; Lijnen HR; Van Herzeele N; Van Hoef B; Demarsin E; Collen D; De Maeyer M
    Thromb Haemost; 1999 Apr; 81(4):479-85. PubMed ID: 10235424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T; Bokarewa M; Zhu Y; Tarkowski A
    Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of staphylokinase in the acquisition of plasmin(ogen)-dependent enzymatic activity by staphylococci.
    Christner RB; Boyle MD
    J Infect Dis; 1996 Jan; 173(1):104-12. PubMed ID: 8537646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.